NCT00004926View on ClinicalTrials.gov

ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Primary Completion Date

August 31, 2002

Study Completion Date

December 31, 2009

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DIETARY_SUPPLEMENT

vitamin D3 analogue ILX23-7553

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

07103-2714

New Jersey Medical School, Newark

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER